The chemotactic activity of normal human polymorphonuclear leukocytes (PMNs) confronted with heat inactivated sera from patients with psoriasis as well as various chronic proliferative diseases was determined using modified Boyden chambers. By the addition of phorbol myristate acetate (PMA) at a concentration of 1 ng/ml the chemoattractant activities of the sera were greatly potentiated. However, the chemotactic migration of normal PMNs was strongly inhibited by sera from patients with long standing and wide spread psoriasis, pyoderma gangrenosum, severe acne conglobata, Sweet syndrome, and some patients with chronic arthritis following rheumatoid fever. In acute guttate psoriasis and atopic dermatitis increased migratory activities were seen.
The inhibition of chemotaxis correlated with increased serum IgA levels as determined by radial immuno diffusion. Column chromatography (Sephacryl S-300) revealed serum fractions of strong inhibitory potency at a molecular weight near 200,000 Dalton. These inhibitory fractions were seen in patients with long standing neutrophil related diseases and could not be detected in normal control sera. It appears that inhibition of PMN chemotaxis is a secondary phenomenon and may play an autoregulatory role in PMN related inflammation.
One of the outstanding features in psoriasis is the migration of polymorphonuclear leukocytes (PMNs) through t h e epidermis toward t h e periphery. These ceUs form micro abscesses a long the inner lining of the stratum corneum in response to a chemotactic stimulus which is believed to be located within the upper epidermis. Several studies have demonstrated ch emotactic complement split products (e.g., C3a, C5a) present in psoriatic scales [1] [2] [3] . Further, serine esterases capable of activating the fifth component into a chemoattractant were found in psoriatic stratum corneum [4] . R ecently it was s hown that the chemotactic activity (CA) of PMNs in psoriasis is greatly increased as compared to nonps orjatic controls, when in the Boyden chamber the celis were confronted with autologous serum [5] . Evidence was presented indicating that fresh sera contained increased ch emo;Ittractan t activi ties after incubation with migrating PMNs [5] In the present study the ability of serum from psoriasis to affect chemotactic responses of PMNs is furth er e xamined with r espect to t h e state of the disease, its duration and the extent of skin involvement.
The results demonstl'ate t h e presence of a circu lating inhibitor of PMN ch emotaxis in long standing psoriasis as welJ as in infla mmatory diseases in which PMN playa major rol e.
MATERIALS AND METHODS

Patients
All patients investigated were hospitalized and agreed to the proposed in vestigations by wri tten co nsent. All blood sa mp les were taken before any therapy was started. Biopsies were ta ken in most of these derm a to logic patients confiJ'ming the clinical diagnosis.
Sera from patients with rh eumatic fever (RF) a nd chronic glomeruloneph ri tis (CG) were kindly provided by Dr. M. Gross, 1 . Department of Internal Medicin e, Un iversity of Kie l. These patients were regularly checked for disease activity. All suffered from progressive joint or kidn ey disease for more than 3 yr.
For co ntrols hea lthy persons (medical personel, students) were selected. They were 21 to 64 yr of age.
Preparation of PMNs
PMNs were isolated by a mod ification of the method desc ribed by H enson (6) . Venous blood from healthy non psoriatic donors was drawn in to 1/6 vol of acid citrate dextrose (0.085 mol Na:l-citrate, 0.065 mol I-I:,-citrate, 2% (w/v) D extran T70, Pharmacia) , placed in disposable plastic tubes and centrifu ged (20 min; 500 g). The supernatan t, the buffy coat, and the upper portion of the erythrocyte sedimen t were removed.
The remaining erythu'ocy tes and PMN containing sediment were gently mix ed with 1-1.5 vol of 2.5% gelatine (Merck) in 0.9% NaC I. Th e cell suspension was allowed to sediment in a waterbath at 37°C for 30 min. The PMN-containing supernatant above the ery throcytes was carefully removed and centrifuged at 20°C (10 min; 400 g). Contaminating erythrocy tes were lysed with 0.85% (w/v) NH.,CI in distilled water. The PMN-suspension was centrifu ged at 4°C (10 min; 150 g) and washed twice with cold medium TC 199. The fina l cell preparation conta ined more than 90% neutrophiJ s with a via bi li ty of greater tha n 95% as assessed by trypan blue excl usion.
Chemotaxis A ssay
50 l ui heat treated (30 min/56°C) serum was dilu ted with 400 l ui medium TC 199 and 50 l uI phorbol myristate acetate (12-0-tetradecanoyl-phorbol-13-acetate, PM A, Sigma) in buffer pH 6,5. This was prepared just before use by dilution of a dimethylsulphoxide stock solution of PMA (1.0 mg/ ml) with ac id sodium acetate buffer, pH 6.5, to a final concentration of 10 ng/ ml. The PMA stock solution was kept frozen between the experiments (7] .
Diluted PMA-serum was placed in the lower co mpartment (150 ~ll) of a mod ified Boyden chamber of the bli nd we ll type. The co mpar tments of the cha mber were separated by a membrane fil ter (cellulose nitrate filter, pore size 5.0 /Lm, Sartorius). The upper co mpar tments were filled with 100 III of the PMN-suspension (3 x 10 H cells / ml). Chambers were incubated for 2.5 hI' at 37°C.
Thereafter the fLlters were removed, fixed with methanol, stained with hematoxylin, cleared with xylene and mounted on glass slides.
All cells prese nt on the lowermost plane of the filter were coun ted (m agnifi ca tion 500 x ). Five random ly selected Ile lds were counted and the average number of cells per high power fi eld (HPF) was expl'essed as the average of dupli cate or trip licate filters. Casein ("Hammarsten," Merck, 4 mg/ml TC 199) was used as a standard chemoattractant for every PMN preparation. The range of cells per HPF was 20-40.
D ec. 1981
T h e chemotactic activity of the specim ens under study was expressed as t h e percentage of chemotactic activity of PMN aga inst casein (= relative chemotactic activity, RCA) [5] according to the fo rmula: mean nu mber of PMNs per hi gh power field
x 100 mean o · casell1 co nt ro per 19h power 1eld
Gel Chrom atograp hy 1.0 Ill] of fi'esh serum (stored below -70°C) was chromatograp hed by u s ing Sephacryl S-300 superfin e (Pharmacia) in Dulbecco's phosp h ate buffe red saline (PBS) . T he di mensions of t he co lumn were 1.5 x 90 cm and the fl ow r ates wer e kept at 5.0 ml per hr resul ti ng in 5.0 rnl fractio ns. E lu ted fractions were measuJ'ed for protein by optical density at 280 nm.
In t he chemotaxis assay P MA was added to eac h fractio n at a final concentration of 1 ng/ ml.
In ord er to o btain an estimate of t he mo lec ular we ight of t he che m otaxis inhi bitor t he column chromatography (Sep hacryl 8 -300 s u perfine) was calibrated using solutions of blue dextra n 2,000, t hyroglobulin (669,000), ferri t in (440,000), catalase (232,000), aldo lase (158,000) a nd cytochj'ome C (12,400). Vo id vo lumes (Vo) we re deterITl i ned by mea ns of blu e dextran 2,000 a nd t he Ve/ Vo was calculated by t he meth od of And rews [8] . For determin ation of IgA the column fract ions were 5-fold co ncent rated (Millipore Ultra fil te rs, excl usion liITlit: 10,000 Daltons) and examined by the method of Ma ncini, Carbonara, a nd H eremans [9] using H yland Immunoplates (H yla nd Traveno l GmbH).
Dose· R esponse of Diffe rent PMA Concentrations on Chemotaxis with Serum.
I n to duplicate vials co ntain ing 50 IIL I heat-inactivated (56°C/ 30 min) serum 400 ILl of TC 199 and 50 IIL I of a fres hly prepared P MA-so lution (in 0.1 M acid sodium acetate buffer, pH 6.5) we re ad ded at a desired fina l co nce ntrat ion of 0.1, 0.5, 1,5, 10, and 100 ng/ ml.
Determin.a.tion of JgA
Serum IgA was determined by t he method of Ma ncini, Carb ona ra, and H erema ns [9] using Hyla nd lmmul1o-plates (Hy la nd T ravenol GITlbH). Th e co nce ntrations ar e give n in mg/ dl (WHO va lues).
RESU LTS
Potentiation of CA by Phorbol-Myristate·Acetate (PMA)
Addition of P MA at various concentrations to the serum resulted in dose-related potent iation of CA (Fig 1) . Maximum i n~reases in CA were present at a concentration of 1 ng PMA / rrU, wi th higher concentration of PMA no further increase of CA was seen, instead, fewer P MNs migrated t hrough t he fil ters. F I G 1. R elative chemotactic activity (R CA, ord inate) of normal human serum (dilu ted 1:10 wit h T C 199) in the prese nce of various con ce ntrations of PMA (abscissa ). P eak chemotactic potentiat ion by P MA is seen at a conce ntra tion of 1 ng/ml. This dose is used in a ll s ubsequent experiments of PMA chemotaxis.
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At a concen tration of 10 ng/ ml which has been sh own to stimulate the release of P MN lysosomal enzymes [10] chemotactic migration was greatly red uced (Fig 1) . R eproducibili ty proved to be adequate in this system . For these reasons a concentration of 1 ng/ml P MA was used in all subseq uent experiments. By the addi tion of PMA to the upper and lower chamber the possibility that this poten tiation of chemotaxIS was in fact caused by increased chemokinesis could be excl uded.
Chemotactic Activity of Sera from Patients with psoriasis
A total of 58 sera fr om patients wi th diffe rent forms of psoriasis was analyzed (Fig 2) . In all cases t he presence of PMA augmented the chem oattractant potency of the sera against normal P MNs. N o difference was fo und in the average RCA between psoriatic and nonpsoriatic sera. This confirms previous observations obt ained with fresh as we U as heatinactivated sera wi thout the use of PMA [5] . In psoriasis wide variations were seen 'as compar ed to the control gr oup (Fig 2) . E ighteen sera demonstrated very low CA (below 100% RCA) wher eas 19 sera showed highly increased chemotactic activity wit h RCA val ues a bove 300%. In the remaining 21 sera no alter ations of PMA indu ced CA were detected (Fig 2) .
FUlt her examination of 10 randomly selected ser a of each of the 2 groups wit h chemotactic abnormalities is presented On Tables r, II. Whereas t he age of the patients and the history of psoriasis did no t var y significantly in the 2 groups, patients with low RCA nearly constantly suffered from the persistent stationary type of psoriasis covering wide aJ'eas of the body (more t han 30-50%, T a ble I). On t he other ha nd high serum chemotactic activity correlated with the presence of relapsing psoriasis predominantly of the gu ttate type (Ta ble II) . Also the skin was affected to a lesser extent as compared to the former group. In view of the fact that PMN ch emotaxis and ra ndom migration is reported to be inhibited by IgA myeloma sera in contrast to IgG myeloma sera [11] the levels of IgA were quantitatively determined by using radial immunodiffusion. Average values for normal healthy persons were 164 ± 76 mg/ dl. In the control persons examined dming this study the average IgA serum levels were close to given standard data. In psoriasis IgA levels averaged 357.8 ± 113.7 mg/dl in t he low responder grou p whereas sera with increased RCA showed low levels of IgA (134.9 ± 29.0 mg/dl) . The differences between the 2 IgA levels were significant (p < 0.001) .
Comparison with Other Inflammatory Diseases
In Table III various inflammatory skin diseases which were examined for serum ch emotactic activity are reported. These include pyoderma gangrenosum, atopic dermatitis, chronic mucocutaneous candidiasis, one patient with severe fi'stulating acne conglobata of the axilla a nd genito-crural region and a patient with Sweet syndrome.
As can be seen inhibitory activity of serum chemotll.xis like that in psoriasis is present in a group of patients with pyoderma gangrenosum, the patient with acne conglobata a nd the patient with Sweet syndrome. The patients with atopic dermatitis showed slightly increased chemotactic activities.
IgA levels paralleled the presence of serum inhibition of chemotaxis, the highest IgA value was found in the acne patient. Low IgA levels were seen in the atopic group (Table III) .
For comparison RCA was determined in 10 patients with chronic arthl'itis following rheumatic fever a nd 10 patients with chronic glomerulonephritis (data not shown) . In addition, 30 healthy persons served as controls. The results revealed abnormallY low RCA in 5 patients with arthritis and one patient with nephritis. IgA levels were not measured except for the controls (164 ± 76 mg/dl). 
Effects of Serum Dilution upon PMN Ch emotaxis
Serum taken from a patient wit h long-standing wide-spread psoriasis was serially diluted with TC 199 after heat inactivation and assayed for RCA in the presence of PMA. Starting at a dilution of 1:32 of this patient's serum the inhibition of PMN migration is gradually lessened (Fig 3) . As can be seen on the same graph the control serum exerts inhibitory effects when applied after 1:2 and 1:4 dilution (Fig 3) ). PMN chemotactic migration is highest when heat inactivated control serum is diluted 1:8 to 1:64 in TC 199 and gradually falls off at further dilution steps. 
Further Characterization of the Inhibitory Component(s) Present in low Responder Sera
Subsequently 10 sera of the low responder group were chro-. ll1atographed using Sephacryl S 300-column chromatography and the RCA of the eluent fractions were measw·ed. Inhibition of RCA was seen with fraction number 9 to 14 (Fig 4) while the rest revealed no major inhibitory activity. The main inhibitory
As revealed by the Mancini technique IgA was present in fraction number 9 to 13 only with a major peak in fraction number 11 (data not shown). These results indicate, that the inhibitory compound may be IgA.
In addition to sera from patients with chronic stationary psoriasis (low responders of chemotaxis) serum from 4 healthy control persons the patient with acne conglobata as well as a patient with pyoderma gangrenosum were chroma to graphed in this manner. In all chromatograms except for the controls defined fractions with strong (80-100%) inhibition of chemotaxis were eluted. The inhibitory peaks were of the same molecular weight range (ca.200,OOO Daltons).
DISCUSSION
In studies reported recently a highly increased chemotactic activity was noted when PMNs from patients with psoriasis were confronted with autologous sera (fresh as well as heat inactivated) [5] . Since wide variations from patient to patient were seen attempts were made to more closely examine the chemotactic activity of serum under standardized conditions. These included the use of PMA, a known tumor promotor which recently has been shown to elicit membrane responses in human PMN [12] . White and Estensen demonstrated the selective release of enzymes of the secondary (specific) granules, when the cells were incubated with PMA at a concentration of 10 ng/ rnl [10] . By adding PMA at concentrations of l.0 ng and 10 ng/rnl to E. coli bacterial fIltrate the chemotactic activity increased up to 700% [7] . This potentiation of leukotaxis by PMA is thought to derive from the stimulatory effect of PMA on cGMP levels already induced by the chemoattractant [13] .
In t he present study the addition of various concentrations of PMA to serum is followed by strong potentiation of RCA (Fig 1) . This result confIrms the fIndings of Estensen et al [7) using a different chemoattractant. As shown below the potentiation of RCA allows more precise discrimination between chemoattractant potencies of serum.
Concentrating upon psoriatic sera we now observed that a proportion of patients (approximately 30% of the present patient grouping) shows abnormal chemotactic activities which range from nearly complete absence of migrating cells to greatly increased chemotactic activity. Analysis of the low responder sera as compared to high responders (Table I, involvement in both groups differs greatly with the low responder group showing considerably more skin affected (50% surface covered) as compared to the high responder group.
Interestingly the inhibitory effect on the migration of normal PMNs was also present in PG, severe acne conglobata and several patients with arthritis. Patients with atopic dermatitis or glomerulonephritis were included in this study as representatives of chronic inflammatory diseases without the predominant involvement of neutrophils. Since no inhibition of RCA was found in the latter diseases, our results indicate, that the inhibition of RCA may be related to tissue alterations in which PMN playa major role.
Furthermore our data suggest a close correlation between the levels of circulating IgA and chemotactic inhibition in psoriasis as well as in other neutrophil related dermatoses (Fig 5) . As an example in patients with chronic stationary psoriasis IgA values were increased ranging from 224 to 575 mg/dl (Table II) . This is in accordance with the findings of Marghescu and BraunFalco [14] and more recently Guilhou et al [15] who found elevated IgA levels in generalized psoriasis. As shown (Table I) these patients demonstrate strong inhibition of RCA. In contrast patients with increased RCA (Table II) showed average IgA levels of 134.9 mg/dl.
This correlation between the ability of heat inactivated serum to inhibit the migratory response of normal PMNs and the serum level of IgA, also seen in PG as well as in the patient with acne conglobata and the case of Sweet syndrome (Table  III) may be a secondary phenomenon due to a prolonged neutrophil related inflammatory response. Recent studies have shown that isolated IgA paraproteins inhibit neutrophil chemotaxis [11] , bactericidal activity [16] and normal serum IgA inhibits phagocytosis of C. albicans [17] . The polymeric (aggregated) forms of IgA appear to be responsible for most of these effects on PMN function [11) . Kemp, Cripps, and Brown observed that isolated IgA from normal human serum inhibits both random as well as chemotactic migration of human PMN [18) . It, is felt that the inhibitory activity may be due to the aggregated forms of IgA as produced during the isolation procedure. Native monomeric IgA present in normal serum is found not to inhibit PMN migl"ation [18] . It has been postulated that polymeric IgA binds to IgA receptors on the PMN [11, 19] and that chemotaxis is suppressed by the Fc receptor binding of IgA [16) . . The present results indicate IgA-associated inhibition of chemotaxis. This inhibition is shown to be increased in diseases, in which PMNs playa major role. The inhibiting principle consistently showed a molecular weight of approximately 200,000 Daltons, which is close to the mol. weight of IgA . By radial immunodiffusion it was demonstrate that this immunoglobu lin was present only in the inhibitory fractions. Therefore it apVol. 77, No.6 pears that the serum factor responsible for the inhibition of human neutrophil chemotaxis is IgA. Further confirmation will be obtained by affinity chromatography, which is in progress.
